SEB J 2008, 22:659?61. 34. Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM, Randhawa MA: Comparative review of Nigella Sativa and triple treatment in eradication of Helicobacter Pylori in sufferers with non-ulcer dyspepsia. Saudi J Gastroenterol 2010, sixteen:207?14. 35. Bamosa AO, Kaatabi H, Lebdaa FM, Elq AM, Al-Sultanb A: Impact of Nigella sativa seeds over the glycemic management of individuals with kind 2 diabetes mellitus. Indian J Physiol Pharmacol 2010, 54:344?54. 36. Badary OA, Al-Shabanah OA, Nagi MN, Al-Bekairi AM, Elmazar MMA: Acute and subchronic toxicity of thymoquinone in mice. Drug Dev Res 1998, 44:56?1. 37. Khalife KH, Lupidi G: Reduction of hypervalent states of myoglobin and hemoglobin to their ferrous varieties by thymoquinone: the role of GSH, NADH and NADPH. Biochim Biophys Acta 2008, 1780:627?37. 38. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF: Several intestinal neoplasia caused by a mutation while in the murine homolog in the APC gene.C12-200 Formula Science 1992, 256:668?70. 39. Musteanu M, Blaas L, Mair M, Schlederer M, Bilban M, Tauber S, Esterbauer H, Mueller M, Casanova E, Kenner L, et al: Stat3 is actually a detrimental regulator of intestinal tumor progression in Apc(Min) mice.Formula of 1932384-22-9 Gastroenterology 2010, 138:1003?011. forty. Ritland SR, Gendler SJ: Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression.PMID:33630067 Carcinogenesis 1999, twenty:51?eight. 41. Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR, et al: Chemoprevention of spontaneous intestinal adenomas from the Apc Min mouse model through the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 1996, 56:710?14. 42. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN: ApcMin, a mutation from the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci USA 1993, 90:8977?981. 43. Becker C, Fantini MC, Wirtz S, Nikolaev A, Kiesslich R, Lehr HA, Galle PR, Neurath MF: In vivo imaging of colitis and colon cancer development in mice employing substantial resolution chromoendoscopy. Gut 2005, 54:950?54. 44. Moolenbeek C, Ruitenberg EJ: The “Swiss roll”: a straightforward strategy for histological studies from the rodent intestine. Lab Anim 1981, 15:57?9. 45. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, Besselsen DG, Godfrey VL, Doetschman T, Dove WF, et al: Pathology of mouse46.47.48.49.50.51.versions of intestinal cancer: consensus report and suggestions. Gastroenterology 2003, 124:762?77. Lopez DS I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES, Gorospe M: Role of your RNA-binding protein HuR in colon carcinogenesis. Oncogene 2003, 22:7146?154. Roig AI, Eskiocak U, Hight SK, Kim SB, Delgado O, Souza RF, Spechler SJ, Wright WE, Shay JW: Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology 2010, 138:1012?021. Campregher C, Schmid G, Ferk F, Knasmuller S, Khare V, Kortum B, Dammann K, Lang M, Scharl T, Spittler A, et al: MSH3-Deficiency Initiates EMAST with out Oncogenic Transformation of Human Colon Epithelial Cells. PLoS One 2012, 7:e50541. Lee JH, Kang Y, Khare V, Jin ZY, Kang MY, Yoon Y, Hyun JW, Chung MH, Cho SI, Jun JY, et al: The p53-inducible gene three (PIG3) contributes to early cellular response to DNA harm. Oncogene 2010, 29:1431?450. Howard S, Deroo T, Fujita Y, Itasaki N: A positive role of ca.